➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
McKesson
Dow
Baxter
Harvard Business School

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Sulforaphane


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Sulforaphane?

Sulforaphane is an investigational drug.

There have been 30 clinical trials for Sulforaphane. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.

The most common disease conditions in clinical trials are Autistic Disorder, Carcinogenesis, and Child Development Disorders, Pervasive. The leading clinical trial sponsors are Johns Hopkins University, National Cancer Institute (NCI), and Evgen Pharma.

There are five hundred and fifty-seven US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Sulforaphane
TitleSponsorPhase
A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia PatientsCentral South UniversityPhase 2
A 12-weeks Study to Evaluate Sulforaphane in the Treatment of DepressionCentral South UniversityPhase 2
Effects of Sulforaphane on Cognitive Function in Patients With Frontal Brain DamageXiangya Hospital of Central South UniversityPhase 2

See all Sulforaphane clinical trials

Clinical Trial Summary for Sulforaphane

Top disease conditions for Sulforaphane
Top clinical trial sponsors for Sulforaphane

See all Sulforaphane clinical trials

US Patents for Sulforaphane

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sulforaphane   Get Started Free Antibody drug conjugates Novartis AG (Basel, CH)   Get Started Free
Sulforaphane   Get Started Free Combined application of isothiocyanate compound and anti-cancer medicine JC (Wuxi) Company, Inc. (Wuxi, Jiangsu, CN)   Get Started Free
Sulforaphane   Get Started Free Seaweed extracts, unsaturated fatty acids, and methods of treatment University of Florida Research Foundation, Incorporated (Gainesville, FL) Smithsonian Institution (Washington, DC)   Get Started Free
Sulforaphane   Get Started Free Anti-CS1 antibodies and antibody drug conjugates AbbVie Biotherapeutics Inc. (Redwood City, CA)   Get Started Free
Sulforaphane   Get Started Free Nutritional composition for promoting gut microbiota balance and health Nestec S.A. (Vevey, CH)   Get Started Free
Sulforaphane   Get Started Free Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA)   Get Started Free
Sulforaphane   Get Started Free Uncatalyzed sigmatropic rearrangement of tyrosine-based compounds King Fahd University of Petroleum and Minerals (Dhahran, SA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sulforaphane

Drugname Country Document Number Estimated Expiration Related US Patent
Sulforaphane Argentina AR102649 2034-11-14   Get Started Free
Sulforaphane Australia AU2015347015 2034-11-14   Get Started Free
Sulforaphane Brazil BR112017009813 2034-11-14   Get Started Free
Sulforaphane Canada CA2967188 2034-11-14   Get Started Free
Sulforaphane Chile CL2017001217 2034-11-14   Get Started Free
Sulforaphane China CN108064244 2034-11-14   Get Started Free
Sulforaphane Costa Rica CR20170200 2034-11-14   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Colorcon
Express Scripts
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.